Issue 21, 2017
From the journal:

RSC Advances

Correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy

Vaibhav Khare,ab   Wejdan Al. Sakarchi,a   Prem N. Gupta,b   Anthony D. M. Curtisa  and  Clare Hoskins*a  

* Corresponding authors

a Institute of Science and Technology in Medicine, Keele University, Keele, Staffordshire, UK
E-mail: c.hoskins@keele.ac.uk

b Formulation and Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India 180001

Abstract

Correction for ‘Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy’ by Vaibhav Khare et al., RSC Adv., 2016, 6, 60126–60137.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C7RA90021J
Article type
Correction
Submitted
13 Feb 2017
Accepted
13 Feb 2017
First published
22 Feb 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 12598-12598

Permissions

Request permissions

Correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy

V. Khare, W. Al. Sakarchi, P. N. Gupta, A. D. M. Curtis and C. Hoskins, RSC Adv., 2017, 7, 12598 DOI: 10.1039/C7RA90021J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements